Predictions for the Generics Industry Land Grab

Biogen to invest $2B in North Carolina manufacturing expansion

Moderna completes Japan R&D facility, pauses domestic manufacturing plan

WuXi Biologics clears FDA inspections at five facilities in China

GenesisM breaks ground on biomanufacturing facility in Massachusetts